# PS-341 and Radiation to Treat Advanced Cancer of the Head and Neck

> **NCT00011778** · PHASE1 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 25 (actual)

## Conditions studied

- Squamous Cell Carcinoma

## Interventions

- **DRUG:** bortezomib
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00011778
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-02-22
- **Primary completion:** 2010-08-26
- **Final completion:** 2013-02-08
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2019-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00011778

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00011778, "PS-341 and Radiation to Treat Advanced Cancer of the Head and Neck". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT00011778. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*